ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 40 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 11 | -100.0% | 0.00% | – |
| Q3 2019 | $223,000 | +14.4% | 56,579 | +20.6% | 0.00% | – |
| Q2 2019 | $195,000 | -87.3% | 46,901 | -78.6% | 0.00% | – |
| Q1 2019 | $1,538,000 | +20.6% | 219,061 | -6.4% | 0.00% | – |
| Q4 2018 | $1,275,000 | -49.5% | 234,060 | -0.5% | 0.00% | – |
| Q3 2018 | $2,527,000 | -18.9% | 235,325 | -1.6% | 0.00% | -100.0% |
| Q2 2018 | $3,116,000 | +44.5% | 239,210 | +22.2% | 0.00% | – |
| Q1 2018 | $2,157,000 | -40.1% | 195,771 | -45.3% | 0.00% | -100.0% |
| Q4 2017 | $3,599,000 | – | 357,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
| AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
| Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
| Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
| Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
| Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
| PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |